Cancer Treatment News and Research

RSS

NHS on the cards for an ailing Australian health system

A new report is recommending a Federal takeover of the Australian public health and dental system - the report by the National Health and Hospitals Reform Commission (NHHRC) says the health system is under strain and in need of a new prescription.

27 Jul 2009

Nanoparticle Trojan horse for ovarian cancer

In a feat of trickery, Dartmouth Medical School immunologists have devised a Trojan horse to help overcome ovarian cancer, unleashing a surprise killer in the surroundings of a hard-to-treat tumor.

19 Jul 2009

"Drops" of gold that burn tumors

At a technical breakfast, Romain Quidant presented his research into the detection and treatment of cancer using gold nanoparticles illuminated with laser light. Quidant, who was recently awarded the Fresnel Prize 2009 that recognizes the highest level of excellence amongst emerging researchers in the field of photonics, is an ICREA researcher at the UPC's Institute of Photonic Sciences (ICFO) and a fellow of the Cellex Foundation Barcelona.

16 Jul 2009

Study finds survival rates from GIST improving among African-Americans

New research published in the July issue of the Journal of the American College of Surgeons reveals that African Americans with gastrointestinal stromal tumors (GIST), a rare cancer that begins in the wall of the gastrointestinal tract, now have survival rates equivalent to those of Caucasians. Prior to 2000, African Americans were more likely to develop GIST and less likely to undergo surgical treatment for this type of cancer.

14 Jul 2009

Overcoming the big ‘nanotech’ challenges

Whether in the fields of medicine, sustainable energy supply or environmental protection, without making use of nanotechnology we will not be capable of overcoming the challenges which the future presents. In parallel with these efforts, though, it is essential that we examine the new technology very carefully for potential risks, such as those presented by free nanoparticles.

14 Jul 2009

Health reformers shy from proposals that would limit treatment options

In a story headlined 'In Retooled Health-Care System, Who Will Say No?' the Washington Post reports: "Although Obama and his advisers have held up providers' spending patterns as the crux of the crisis, proposals in Washington go only so far in addressing the thorniest questions about who gets what care."

8 Jul 2009

Senior breast cancer patients receive ‘chemo’ if treated in private practices

In a study to determine the non-medical factors that may be associated with the decision to treat nonmetastatic breast cancer, researchers at Columbia University Mailman School of Public Health evaluated the association between oncologist characteristics and the receipt of chemotherapy in elderly women with breast cancer and found that they were more likely to receive chemotherapy if treated by oncologists employed in a private practice.

7 Jul 2009

Survivors of childhood cancer at greater risk of birth complications when pregnant

Survivors of childhood cancer run particular risks when pregnant and should be closely monitored, the 25th annual conference of the European Society of Human Reproduction and Embryology heard this week.

2 Jul 2009

First baby born after new ovarian transplant technique

A new technique for transplanting the ovaries of women who have lost their fertility as a result of cancer treatment was outlined to the 25th annual conference of the European Society of Human Reproduction and Embryology today (Monday 29 June).

29 Jun 2009

Diet and exercise to alleviate treatments for prostate cancer

A DVD, developed by academics at the University of Hertfordshire, which illustrates the positive effects of diet and exercise in the treatment of prostate cancer, will be launched tomorrow.

23 Jun 2009

Discovery of potent metastasis inhibitor

Researchers at Children's Hospital Boston have isolated a potent inhibitor of tumor metastasis made by tumor cells, one that could potentially be harnessed as a cancer treatment.

23 Jun 2009

Antisense Therapeutics trial of ATL1101 in prostate cancer shows promise

Antisense Therapeutics Ltd. (ASX: ANP) has reported further positive results from its collaborative preclinical research studies on the therapeutic potential of ATL1101 in prostate cancer. In experimental models, ATL1101 treatment significantly enhanced the tumor-suppressive effect of the cancer drug Paclitaxel. Paclitaxel is one of a class of drugs known as taxanes.

18 Jun 2009

Novel light-sensitive compounds show promise for photodynamic cancer therapy

Chemists at the University of California, Santa Cruz, have developed novel compounds that show promise for photodynamic cancer therapy, which uses light-activated drugs to kill tumor cells.

17 Jun 2009

Taxol-carrying nanoparticles

Nanoparticles specially engineered by University of Central Florida Assistant Professor J. Manuel Perez and his colleagues could someday target and destroy tumors, sparing patients from toxic, whole-body chemotherapies.

17 Jun 2009

New form of radiotherapy could revolutionize treatment for recurrent prostate cancer

A new study shows that an alpha-particle emitting radiopeptide - radioactive material bound to a synthetic peptide, a component of protein - is effective for treating prostate cancer in mice, according to researchers at SNM's 56th Annual Meeting in Toronto.

15 Jun 2009

Research leads to advanced trials of new cancer treatment

Prof. Hochberg was successful in isolating the H19 gene in humans and determining that it is significantly expressed in over 33 different forms of cancer, including superficial bladder carcinoma and pancreatic, ovarian and metastatic liver cancer, while laying dormant and non-expressed in non-cancerous cells.

15 Jun 2009

Prevalence and predictors of antioxidant supplement use during breast cancer treatment

A new study finds that many women with breast cancer take antioxidant supplements while undergoing cancer treatment, even though the consequences of doing so are unknown.

9 Jun 2009

Cisplatin doubles lung cancer survival time in mice

A lung cancer treatment that inhibits nicotine receptors was shown to double survival time in mice, according to Italian researchers.

9 Jun 2009

Prophylactic cranial irradiation prevents early lung cancer metastases to the brain

A national Radiation Therapy Oncology Group (RTOG) study led by a Medical College of Wisconsin Cancer Center physician at Froedtert Hospital in Milwaukee has found that a course of radiation therapy to the brain after treatment for locally advanced non-small cell lung cancer reduced the risk of metastases to the brain within the first year after treatment. The study was presented at the American Society of Clinical Oncology annual meeting in Orlando, June 1.

3 Jun 2009

Bringing life back into the bedroom for cancer survivors

For the more than 6 million female cancer survivors living in the U.S. today, the celebration of continued life and love can be interrupted by cancer treatment's side effects, including in the bedroom. Experts at The University of Texas M. D. Anderson Cancer Center offer survivors advice on how to get their relationships back on track.

2 Jun 2009